Stifel Financial signed a definitive agreement to acquire Torreya Partners, an independent M&A and private capital advisory firm serving the global life sciences industry. Terms of the transaction were not disclosed.

Founded in 2007, Torreya has deep specialization within life sciences, including biotechnology and pharmaceuticals. In addition to its core M&A business, Torreya also offers advisory expertise across divestitures and joint ventures, royalty monetization, licensing agreements and private capital raising. With a team of more than 40 professionals located in New York, London and Mumbai, Torreya maintains an international presence in a sector that demands cross-border capabilities and global reach.

“One in five dollars spent in the United States, and a growing percentage globally, is healthcare-related,” Ronald J. Kruszewski, chairman and CEO of Stifel, said. “This combination brings together two like-minded firms that drive innovation with forward thinking and creative solutions for clients. I look forward to welcoming the Torreya team to Stifel.”

“Over the past 15 years, Torreya has built a strong reputation as a trusted advisor to global life sciences companies, especially in complex and transformational deals that often require unique approaches and structures,” Brad Raymond, global head of investment banking at Stifel, said. “We have been very impressed with the breadth and quality of Torreya’s relationships, which include entrepreneurs and growth-focused corporations, along with venture capitalists and specialty healthcare investors. Without question, this partnership helps solidify Stifel’s leadership position across healthcare.”

Led by co-heads Mark Dempster and Declan Quirke, Stifel’s global healthcare investment banking team has advised on approximately 700 total M&A and capital raising transactions since 2010. Stifel’s presence in the healthcare sector includes a dedicated equity research offering (15 publishing analysts covering 245 companies worldwide), a dedicated specialist sales force and a flagship annual healthcare conference, which attracts nearly 1,000 industry participants.

“We view Stifel as the right partner to help us accelerate growth across industry, product and geographic coverage,” Tim Opler, managing director and co-founder of Torreya Partners, said. “In addition to sharing common values and a client-first approach, we have been impressed by the Stifel team’s proven results and continued momentum across the healthcare sector. Together, we are well positioned to serve clients and execute transactions that lead to medical advances and ultimately improve people’s lives.”